Traditional Drug Developers Have Mostly Seen Smoother Sailing Than Biotechs

Overall, the top 10 pharma companies on this year’s GEN list generated a combined $1.722 trillion in market cap, up 9.8%.

Written by Alex Phillippidis | Read More